论文部分内容阅读
我国是肝病大国,肝病危害性大,患病人数多,是近年来重点研究的对象。而肝纤维化是很多慢性肝病的致病因素,及早发现肝纤维化并有效治疗甚至逆转是阻止疾病恶化的理想方法。目前,肝移植还是主要治疗肝纤维化甚至肝硬化的主要途径,但是由于其肝源缺乏,费用也相对较高,手术并发症,排异反应等弊端,越来越多的学者把目光投向了其他方法。近年来有研究表明骨髓间充质干细胞能够有效治疗肝纤维化,同时也有一些声音认为不能有效治疗肝纤维化甚至有些学者认为骨髓间充质干细胞对肝纤维化有促进作用。该文就此进行综述。
Our country is a large country of liver disease, liver disease, large number of illnesses, is the focus of research in recent years. Liver fibrosis is a causal factor in many chronic liver diseases. Early detection of liver fibrosis and effective treatment and even reversal are the ideal methods to prevent the disease from deteriorating. At present, liver transplantation is the main approach to treat liver fibrosis and even cirrhosis. However, due to its lack of liver source, relatively high cost, complications of operation and abnormal response, more and more scholars have turned their attention to Other methods. In recent years, studies have shown that bone marrow mesenchymal stem cells can effectively treat liver fibrosis, but there are also some voices that can not effectively treat liver fibrosis. Some scholars even think that bone marrow mesenchymal stem cells promote liver fibrosis. This article reviews this.